Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial

The purpose of this study was evaluating the efficacy and safety of intravenous (IV) ampicillin–sulbactam plus nebulized colistin in the treatment of Ventilator-Associated Pneumonia (VAP) caused by MDR Acinetobacter (MDRA) in ICU patients as an alternative to IV plus nebulized colistin. In this sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourheidar, Elham, Haghighi, Mehrdad, Kouchek, Mehran, Miri, Mir Mohammad, Shojaei, Seyedpouzhia, Salarian, Sara, Hassanpour, Rezvan, Sistanizad, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393051/
https://www.ncbi.nlm.nih.gov/pubmed/32802106
http://dx.doi.org/10.22037/ijpr.2019.112466.13775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393051/
https://www.ncbi.nlm.nih.gov/pubmed/32802106
http://dx.doi.org/10.22037/ijpr.2019.112466.13775

Ejemplares similares